Capricor Therapeutics Operating Margin 2006-2019 | CAPR

Current and historical operating margin for Capricor Therapeutics (CAPR) over the last 10 years. The current operating profit margin for Capricor Therapeutics as of December 31, 2019 is -761.59%.
Capricor Therapeutics Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2019-12-31 $0.00B $-0.01B inf%
2019-09-30 $0.00B $-0.01B -1000.00%
2019-06-30 $0.00B $-0.01B -1200.00%
2019-03-31 $0.00B $-0.01B -1400.00%
2018-12-31 $0.00B $-0.02B -1500.00%
2018-09-30 $0.00B $-0.02B inf%
2018-06-30 $0.00B $-0.01B inf%
2018-03-31 $0.00B $-0.01B -1300.00%
2017-12-31 $0.00B $-0.01B -650.00%
2017-09-30 $0.00B $-0.01B -433.33%
2017-06-30 $0.00B $-0.02B -375.00%
2017-03-31 $0.00B $-0.02B -425.00%
2016-12-31 $0.00B $-0.02B -425.00%
2016-09-30 $0.00B $-0.02B -425.00%
2016-06-30 $0.00B $-0.02B -375.00%
2016-03-31 $0.00B $-0.01B -325.00%
2015-12-31 $0.01B $-0.01B -240.00%
2015-09-30 $0.01B $-0.01B -220.00%
2015-06-30 $0.01B $-0.01B -180.00%
2015-03-31 $0.01B $-0.01B -140.00%
2014-12-31 $0.00B $-0.01B -125.00%
2014-09-30 $0.00B $-0.01B -166.67%
2014-06-30 $0.00B $-0.01B -250.00%
2014-03-31 $0.00B $-0.01B -600.00%
2013-12-31 $0.00B $-0.01B inf%
2013-09-30 $0.00B $-0.00B -200.00%
2012-12-31 $0.00B $-0.00B -150.00%
2012-03-31 $0.00B $-0.01B -500.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.004B $0.001B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.105B 24.52
Medtronic (MDT) Ireland $115.616B 15.54
Stryker (SYK) United States $55.501B 17.93
Boston Scientific (BSX) United States $43.519B 19.60
Baxter (BAX) United States $41.301B 0.00
Coloplast (CLPBY) Denmark $32.381B 49.97
Lonza Group Ag (LZAGY) Switzerland $30.517B 0.00
Terumo (TRUMY) Japan $24.814B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $23.088B 0.00
ResMed (RMD) United States $22.122B 38.44
Zimmer Biomet Holdings (ZBH) United States $18.991B 11.69
Smith & Nephew SNATS (SNN) United Kingdom $14.868B 0.00
Sunny Optical Technology (SNPTF) China $14.665B 0.00
Bio-Rad Laboratories (BIO) United States $10.946B 51.16
Insulet (PODD) United States $10.367B 634.31
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $7.034B 20.23
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
GN STORE NORD (GNNDY) Denmark $6.057B 0.00
Perrigo (PRGO) Ireland $6.039B 11.01
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Haemonetics (HAE) United States $4.949B 30.46
Canopy Growth (CGC) Canada $4.629B 0.00
ICU Medical (ICUI) United States $4.256B 27.80
Quidel (QDEL) United States $3.979B 34.93
Neogen (NEOG) United States $3.373B 57.14
Agios Pharmaceuticals (AGIO) United States $2.569B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.529B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.354B 0.00
NuVasive (NUVA) United States $2.269B 17.54
Envista Holdings (NVST) United States $2.062B 0.00
National Vision Holdings (EYE) United States $1.337B 22.53
AtriCure (ATRC) United States $1.273B 0.00
Cardiovascular Systems (CSII) United States $1.210B 0.00
Aurora Cannabis (ACB) Canada $0.986B 0.00
TG Therapeutics (TGTX) United States $0.979B 0.00
Phibro Animal Health (PAHC) United States $0.961B 19.01
NanoString Technologies (NSTG) United States $0.862B 0.00
VAREX IMAGING (VREX) United States $0.798B 16.58
DFB Healthcare Acquisitions (AHCO) United States $0.761B 0.00
Aphria (APHA) $0.754B 0.00
Cerus (CERS) United States $0.741B 0.00
Omeros (OMER) United States $0.663B 0.00
OraSure Technologies (OSUR) United States $0.639B 79.31
InMode (INMD) Israel $0.619B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.595B 35.39
PetIQ (PETQ) United States $0.582B 15.83
Quanterix (QTRX) United States $0.547B 0.00
LeMaitre Vascular (LMAT) United States $0.462B 26.00
Surmodics (SRDX) United States $0.432B 49.69
Owens & Minor (OMI) United States $0.427B 11.69
Lantheus Holdings (LNTH) United States $0.411B 9.23
Vapotherm (VAPO) United States $0.381B 0.00
Meridian Bioscience (VIVO) United States $0.363B 14.60
Zynex (ZYXI) United States $0.327B 35.61
Repro-Med Systems (KRMD) United States $0.298B 188.00
Utah Medical Products (UTMD) United States $0.292B 20.87
Organigram Holdings (OGI) Canada $0.280B 0.00
MacroGenics (MGNX) United States $0.257B 0.00
Cytosorbents (CTSO) United States $0.236B 0.00
BioLife Solutions (BLFS) United States $0.201B 123.00
Female Health (VERU) United States $0.196B 0.00
HEXO (HEXO) $0.192B 0.00
Viemed Healthcare (VMD) United States $0.164B 18.52
Exagen (XGN) United States $0.162B 0.00
United Health Products (UEEC) United States $0.132B 0.00
Evolus (EOLS) United States $0.130B 0.00
Rockwell Medical (RMTI) United States $0.124B 0.00
Bovie Medical (APYX) United States $0.122B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.110B 0.00
Liberty Health Sciences (LHSIF) Canada $0.105B 0.00
Fonar (FONR) United States $0.093B 6.78
Chimerix (CMRX) United States $0.082B 0.00
Brainsway (BWAY) Israel $0.080B 0.00
MTech Acquisition (KERN) United States $0.069B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.062B 0.00
United-Guardian (UG) United States $0.061B 12.69
Nephros (NEPH) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
Surface Oncology (SURF) United States $0.047B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
ImmuCell (ICCC) United States $0.030B 0.00
FSD PHARMA INC (HUGE) Canada $0.024B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00